EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:6375 - lansoprazole
| Formula | C16H14F3N3O2S |
| Net Charge | 0 |
| Average Mass | 369.368 |
| Monoisotopic Mass | 369.07588 |
| SMILES | Cc1c(OCC(F)(F)F)ccnc1CS(=O)c1nc2ccccc2n1 |
| InChI | InChI=1S/C16H14F3N3O2S/c1-10-13(20-7-6-14(10)24-9-16(17,18)19)8-25(23)15-21-11-4-2-3-5-12(11)22-15/h2-7H,8-9H2,1H3,(H,21,22) |
| InChIKey | MJIHNNLFOKEZEW-UHFFFAOYSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Biological Roles: | EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor An EC 3.6.3.* (acid anhydride hydrolase catalysing transmembrane movement of substances) inhibitor that inhibits H+/K+-exchanging ATPase, EC 3.6.3.10. Such compounds are also known as proton pump inhibitors. analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. antibacterial agent A substance (or active part thereof) that kills or slows the growth of bacteria. |
| Applications: | hypoglycemic agent A drug which lowers the blood glucose level. gout suppressant A drug that increases uric acid excretion by the kidney (uricosuric drug), decreases uric acid production (antihyperuricemic), or alleviates the pain and inflammation of acute attacks of gout. antifibrotic agent Any agent which acts to reduce fibrosis. antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. anti-ulcer drug One of various classes of drugs with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| lansoprazole (CHEBI:6375) has role analgesic (CHEBI:35480) |
| lansoprazole (CHEBI:6375) has role anti-ulcer drug (CHEBI:49201) |
| lansoprazole (CHEBI:6375) has role antibacterial agent (CHEBI:33282) |
| lansoprazole (CHEBI:6375) has role antifibrotic agent (CHEBI:233423) |
| lansoprazole (CHEBI:6375) has role antineoplastic agent (CHEBI:35610) |
| lansoprazole (CHEBI:6375) has role EC 3.6.3.10 (H+/K+-exchanging ATPase) inhibitor (CHEBI:49200) |
| lansoprazole (CHEBI:6375) has role gout suppressant (CHEBI:35845) |
| lansoprazole (CHEBI:6375) has role hypoglycemic agent (CHEBI:35526) |
| lansoprazole (CHEBI:6375) is a benzimidazoles (CHEBI:22715) |
| lansoprazole (CHEBI:6375) is a pyridines (CHEBI:26421) |
| lansoprazole (CHEBI:6375) is a sulfoxide (CHEBI:22063) |
| IUPAC Name |
|---|
| 2-({[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methyl}sulfinyl)-1H-benzimidazole |
| INNs | Source |
|---|---|
| lansoprazol | ChemIDplus |
| lansoprazolum | ChemIDplus |
| Synonyms | Source |
|---|---|
| AG 1749 | DrugBank |
| Agopton | ChEMBL |
| Lansoprazole | ChEMBL |
| Lansox | ChEMBL |
| Lanzoprazole | ChEMBL |
| Lanzor | ChEMBL |
| Brand Names | Source |
|---|---|
| Bamalite | DrugBank |
| Lansoprazole component of prevpac | ChEMBL |
| Lanzol | DrugBank |
| Lanzopral | DrugBank |
| Lanzul | ChEBI |
| Limpidex | DrugBank |
| Registry Numbers | Sources |
|---|---|
| Beilstein:4333393 | Beilstein |
| CAS:103577-45-3 | ChemIDplus |
| Citations |
|---|